Establishment and application of a human osteosarcoma U-2OS cell line that can stably express Cas9 protein
Authors:
- 20 April 2022
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 477 (9) , 2183-2191
Abstract
Osteosarcoma is the most common primary malignant bone tumor, and U-2OS is a common osteosarcoma cell model. The study obtained a human osteosarcoma U-2OS tool cell line which could stably express Cas9 protein, and we reported its production method and application. Firstly, we introduced a Cas9 protein expression gene and an antibiotic screening marker gene through CRISPR/Cas9 system to construct a human osteosarcoma U-2OS tool cell line which could stably express Cas9 protein. Secondly, as the cell line could stably express Cas9 protein, it was only transfected alone a small sgRNA fragment for related gene editing, we then transfected, respectively, a small ETV4 and MALAT1 sgRNA fragment to U-2OS tool cell line for gene editing. Lastly, the Q-PCR results showed that the transcription levels of ETV4 and MALAT1 were significantly decreased, and western blotting result showed that the translation level of ETV4 was significantly decreased, these results indicated that the constructed U-2OS tool cell line could effectively edit protein-coding gene (ETV4) and long non-coding RNA gene (MALAT1). The results of this study also indicated that the constructed U-2OS tool cell line could greatly improve the efficiency of gene editing. Therefore, the genetic engineering cell line provided by the study is of great significance for studying the pathogenesis and regulatory network of osteosarcoma, and for preventing and treating bone tumor as soon as possible.Keywords
Funding Information
- The Talent Introduction Project of Changsha University (SF1815)
- Scientific Research Foundation of Hunan Provincial Education Department (20B058)
This publication has 35 references indexed in Scilit:
- Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cellsDevelopment, 2017
- Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistanceOncotarget, 2016
- Nuclear domain ‘knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editingNucleic Acids Research, 2015
- Transgene integration into the human AAVS1 locus enhances myosin II-dependent contractile force by reducing expression of myosin binding subunit 85Biochemical and Biophysical Research Communications, 2015
- Enriching CRISPR-Cas9 targeted cells by co-targeting the HPRT geneNucleic Acids Research, 2015
- Development and Applications of CRISPR-Cas9 for Genome EngineeringCell, 2014
- High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cellsNature, 2014
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonucleaseNature Biotechnology, 2013
- OVEREXPRESSION OF IL-6 BUT NOT IL-8 INCREASES PACLITAXEL RESISTANCE OF U-2OS HUMAN OSTEOSARCOMA CELLSCytokine, 2002